Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice

Brain Research

Volumn 1005, Issue 1-2, 2004, Pages 29-35

  Bolivar, Valerie J ^a   Manley, Kevin ^a   Messer, Anne ^a  

^a NONE

Author keywords

Degenerative disease: other; Disorders of the nervous system; Exploratory behavior; Huntington's disease; Mouse; R6 1

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HABITUATION; HUNTINGTON CHOREA; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; ONSET AGE; PATHOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; STEREOTYPY; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; HUNTINGTON DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOTOR ACTIVITY; TRINUCLEOTIDE REPEATS;

EID: 1642418261     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.01.021     Document Type: Article

References (41)

1. Bates G., Harper P.S., Jones L. Huntington's Disease. 3rd ed. 2002;Oxford Univ. Press, Oxford. 558 pp.
2. Bolivar V., Flaherty L. A region on chromosome 15 controls intersession habituation in mice. J. Neurosci. 23:2003;9435-9438.
3. Bolivar V.J., Caldarone B.J., Reilly A.A., Flaherty L. Habituation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav. Genet. 30:2000;285-293.
4. Bolivar V.J., Ganus J.S., Messer A. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse. Brain Res. 937:2002;74-82.
5. Bolivar V.J., Manley K., Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease trangenic mice. Behav. Neurosci. 117:2003;1233-1242.
6. Cha J.-H.J., Frey A.S., Alsdorf S.A., Kerner J.A., Kosinski C.M., Mangiarini L., Penney J.B. Jr., Davies S.W., Bates G.P., Young A.B. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos. Trans. R. Soc., B. 354:1999;981-989.
7. Clifford J.J., Drago J., Natoli A.L., Wong J.Y.F., Kinsella A., Waddington J.L., Vaddadi K.S. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience. 109:2002;81-88.
8. Cook M.N., Bolivar V.J., McFadyen M.P., Flaherty L. Behavioral differences among 129 substrains: implications for knockout and transgenic mice. Behav. Neurosci. 116:2002;600-611.
9. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
10. Deckel A.W., Volmer P., Weiner R., Gary K.A., Covault J., Sasso D., Schmerler N., Watts D., Yan Z., Abeles I. Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice. Brain Res. 875:2000;187-195.
11. Djousse L., Knowlton B., Cupples L.A., Marder K., Shoulson I., Myers R.H. Weight loss in early stage of Huntington's disease. Neurology. 59:2002;1325-1330.
12. Dudek B.C., Tritto T. Biometrical genetic analysis of ethanol's psychomotor stimulant effect. Alcohol. Clin. Exp. Res. 18:1994;956-963.
13. Folstein S.E. Huntington's Disease. A Disorder of Families. 1989;Johns Hopkins Univ. Press, Baltimore. 251 pp.
14. Hansson O., Castihlo R.F., Korhonen L., Lindholm D., Bates G.P., Brundin P. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. J. Neurochem. 78:2001;694-703.
15. Hansson O., Guatteo E., Mercuri N.B., Bernardi G., Li X.-J., Castilho R.F., Brundin P. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur. J. Neurosci. 14:2001;1492-1504.
16. Hansson O., Petersen A., Leist M., Nicotera P., Castilho R.F., Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8727-8732.
17. Hayden M.R. Huntington's Chorea. 1981;Springer-Verlag, New York. 192 pp.
18. Helmlinger D., Yvert G., Picaud S., Merienne K., Sahel J., Mandel J.-L., Devys D. Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice. Hum. Mol. Genet. 11:2002;3351-3359.
19. Hockly E., Woodman B., Mahal A., Lewis C.M., Bates G. Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res. Bull. 61:2003;469-479.
20. Iannicola C., Moreno S., Oliverio S., Nardacci R., Ciofi-Luzzatto A., Piacentini M. Early alterations in gene expression and cell morphology in a mouse model of Huntington's disease. J. Neurochem. 75:2000;830-839.
21. Lievens J.-C., Woodman B., Mahal A., Spasic-Boscovic O., Samuel D., Kerkerian-Le Goff L., Bates G.P. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis. 8:2001;807-821.
22. Luesse H.-G., Schiefer J., Spruenken A., Puls C., Block F., Kosinski C.M. Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus. Behav. Brain Res. 126:2001;185-195.
23. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
24. Menalled L.B., Chesselet M.-F. Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23:2002;32-39.
25. Menalled L.B., Sison J.D., Wu Y., Olivieri M., Li X.-J., Li H., Zeitlin S., Chesselet M.-F. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci. 22:2002;8266-8276.
26. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., Chesselet M.-F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 465:2003;11-26.
27. Nadel L. Dorsal and ventral hippocampal lesions and behavior. Physiol. Behav. 3:1968;891-900.
28. Naver B., Stub C., Moller M., Fenger K., Hansen A.K., Hasholt L., Sorensen S.A. Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience. 122:2003;1049-1057.
29. NicNiocaill B., Haraldsson B., Hansson O., O'Connor W.T., Brundin P. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur. J. Neurosci. 13:2001;206-210.
30. O'Keefe J., Nadel L. The Hippocampus as a Cognitive Map. 1978;Clarendon Press, Oxford. 584 pp.
31. Perez-Severiano F., Rios C., Segovia J. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res. 862:2000;234-237.
32. Petersen A., Hansson O., Puschban Z., Sapp E., Romero N., Castilho R.F., Sulzer D., Rice M., DiFiglia M., Przedborski S., Brundin P. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. Eur. J. Neurosci. 14:2001;1425-1435.
33. Reddy P.H., Williams M., Charles V., Garrett L., Pike-Buchanan L., Whetsell W.O. Jr., Miller G., Tagle D.A. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 20:1998;198-202.
34. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18:2002;202-209.
35. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.-Z., Li X.-J., Simpson E.M., Gutekunst C.-A., Leavitt B.R., Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12:2003;1555-1567.
36. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
37. Thorpe W.H. Learning and Instinct in Animals. 1956;Methuen, London. 493 pp.
38. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G.P., Davies S.W. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8093-8097.
39. van Dellen A., Blakemore C., Deacon R., York D., Hannan A.J. Delaying the onset of Huntington's in mice. Nature. 404:2000;721-722.
40. van Dellen A., Welch J., Dixon R.M., Cordery P., York D., Styles P., Blakemore C., Hannan A.J. N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice. NeuroReport. 11:2000;3751-3757.
41. van Dellen A., Deacon R., York D., Blakemore C., Hannan A.J. Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Res. Bull. 56:2001;313-318.